ELORALINTIDE

Description

Eloralintide, also known as LY3841136, is a long-acting peptide analog designed to selectively activate amylin receptors. It is studied in experimental settings involving receptor binding, appetite-related signaling, energy regulation, gastric motility, metabolic pathways, and the pharmacological properties of selective amylin-receptor agonists.

Eloralintide remains an investigational compound and is not an FDA-approved drug product. It should not be represented as a treatment for obesity, diabetes, appetite control, weight management, or any other human condition. For Research Use Only. Not for human or veterinary use, ingestion, administration, diagnostic procedures, or therapeutic applications.